These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 24350938)

  • 21. Congestive Hepatopathy.
    Fortea JI; Puente Á; Cuadrado A; Huelin P; Pellón R; González Sánchez FJ; Mayorga M; Cagigal ML; García Carrera I; Cobreros M; Crespo J; Fábrega E
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [13C breath tests: a useful tool to quantify hepatic reserve function].
    Qu XH; Huang XL; Cai MC; Chen ZW; Lu LG; Yan WL; Huang G
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):318-20. PubMed ID: 19403038
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiohepatic Interactions: Implications for Management in Advanced Heart Failure.
    Pendyal A; Gelow JM
    Heart Fail Clin; 2016 Jul; 12(3):349-61. PubMed ID: 27371512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right-Sided Heart Failure and the Liver.
    Mauriello JN; Straughan MM
    Crit Care Nurs Clin North Am; 2022 Sep; 34(3):341-350. PubMed ID: 36049853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of abnormal liver tests.
    Woreta TA; Alqahtani SA
    Med Clin North Am; 2014 Jan; 98(1):1-16. PubMed ID: 24266911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of the heart and the liver.
    Møller S; Bernardi M
    Eur Heart J; 2013 Sep; 34(36):2804-11. PubMed ID: 23853073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart Failure and Liver Disease: Cardiohepatic Interactions.
    Xanthopoulos A; Starling RC; Kitai T; Triposkiadis F
    JACC Heart Fail; 2019 Feb; 7(2):87-97. PubMed ID: 30553904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.
    Møller S
    Dan Med Bull; 1998 Feb; 45(1):1-14. PubMed ID: 9504263
    [No Abstract]   [Full Text] [Related]  

  • 29. Epigenetic-sensitive challenges of cardiohepatic interactions: clinical and therapeutic implications in heart failure patients.
    Benincasa G; Cuomo O; Vasco M; Vennarecci G; Canonico R; Della Mura N; Alfano R; Napoli C
    Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1247-1253. PubMed ID: 32773512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organ-specific responses to circulatory disturbances in heart failure: new insights.
    Argulian E; McPherson C; Kukin M
    Congest Heart Fail; 2012; 18(2):127-31. PubMed ID: 22432559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing hemodynamics noninvasively in patients with heart failure.
    Dokainish H
    Curr Opin Cardiol; 2016 Sep; 31(5):493-500. PubMed ID: 27258534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous measurement of bromsulphalein initial distribution volume and 131I-albumin plasma volume in patients with liver disease. A study of 195 patients and a review of the literature.
    den Blaauwen DH; Thijs LG; Roos P
    Acta Gastroenterol Belg; 1974; 37(7):313-38. PubMed ID: 4138587
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiohepatic interactions in heart failure: an overview and clinical implications.
    Samsky MD; Patel CB; DeWald TA; Smith AD; Felker GM; Rogers JG; Hernandez AF
    J Am Coll Cardiol; 2013 Jun; 61(24):2397-2405. PubMed ID: 23603231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspects.
    Møller S; Henriksen JH; Bendtsen F
    World J Gastroenterol; 2014 Nov; 20(42):15499-517. PubMed ID: 25400435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congestive hepatopathy and hypoxic hepatitis in heart failure: a cardiologist's point of view.
    Kavoliuniene A; Vaitiekiene A; Cesnaite G
    Int J Cardiol; 2013 Jul; 166(3):554-8. PubMed ID: 22656043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart diseases affecting the liver and liver diseases affecting the heart.
    Naschitz JE; Slobodin G; Lewis RJ; Zuckerman E; Yeshurun D
    Am Heart J; 2000 Jul; 140(1):111-20. PubMed ID: 10874271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The prognostic value of liver function tests--clinical aspects, laboratory chemical parameters and quantitative function tests].
    Wahlländer A; Beuers U
    Leber Magen Darm; 1990 May; 20(3):115-6, 119-23, 126-8. PubMed ID: 2198410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Definition and classification of heart failure].
    Urbaszek W
    Z Kardiol; 1991; 80 Suppl 8():7-12. PubMed ID: 1796637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver disease and heart failure.
    Correale M; Tricarico L; Leopizzi A; Mallardi A; Mazzeo P; Tucci S; Grazioli D; Di Biase M; Brunetti ND
    Panminerva Med; 2020 Mar; 62(1):26-37. PubMed ID: 31670498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: quantitative tests of liver function.
    Jalan R; Hayes PC
    Aliment Pharmacol Ther; 1995 Jun; 9(3):263-70. PubMed ID: 7654888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.